Skip to content

Advertisement

Open Peer Review Reports for: TH1/TH2 Cytokine profile in relapsing-remitting multiple sclerosis patients treated with Glatiramer acetate or Natalizumab

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
9 Apr 2012 Submitted Original manuscript
25 Jun 2012 Reviewed Reviewer Report - Oliver Neuhaus
10 Jul 2012 Reviewed Reviewer Report - Thomas Scott
27 Aug 2012 Author responded Author comments - Celia Oreja-Guevara
Resubmission - Version 2
27 Aug 2012 Submitted Manuscript version 2
28 Aug 2012 Reviewed Reviewer Report - Thomas Scott
11 Sep 2012 Reviewed Reviewer Report - Oliver Neuhaus
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
11 Sep 2012 Editorially accepted
18 Sep 2012 Article published 10.1186/1471-2377-12-95

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement